Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Lauren L. Mayo Image

      Lauren L. Mayo, M.D.

      Department of Radiation Oncology, Division of Radiation Oncology

      About Dr. Mayo

      Dr. Mayo earned her medical degree from The University of Texas Medical Branch (UTMB) in Galveston, TX. She completed her internship at The Methodist Hospital and then spent a year of radiology training at New York University. She returned back to Texas to complete her residency and serve as chief resident in radiation oncology at The University of Texas Medical Branch with an integrated training at MD Anderson Cancer Center. During her training she received several awards including being nominated as the Outstanding Overall Resident at UTMB, held active national leadership roles in the American College of Radiology, and remains a member of the Alpha Omega Alpha medical honor society and American Society for Radiation Oncology. She then joined the faculty of MD Anderson where she treats all disease sites but has a special interest in head and neck cancer and genitourinary malignancies.

      Read More

      Meet Lauren Mayo, M.D.

      Present Title & Affiliation

      Primary Appointment

      Assistant Medical Director Of League City Radiation Oncology, Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Genitourinary Radiation Oncology, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2009University of Texas Medical Branch, Galveston, Texas, US, MD
      2005The University of Texas at Austin, Austin, Texas, US, Finance, with minor in Biology, BA

      Postgraduate Training

      2012-2012Clinical Residency, Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center, Houston, TX. Ten months of clinical training integrated into UTMB residency: lymphoma, CNS, pediatrics, Head & Neck, Thoracic, and Genitourinary, Dr. Christopher Crane, M.D, Houston, Texas
      2011-2014Clinical Residency, Department of Radiation Oncology, University of Texas Medical Branch (UTMB), Galveston, Texas
      2010-2011Clinical Residency, Department of Radiology, New York University Langone Medical Center, New York, New York
      2009-2010Clinical Internship, Department of Internal Medicine, Transitional Intern, The Methodist Hospital, Houston, Texas

      Licenses & Certifications

      2023Florida Board of Medicine
      2023Oklahoma State Board of Medical Licensure
      2023Arizona Board of Medical Examiners
      2023Georgia Composite Medical Board
      2023Louisiana State Board of Medical Examiners
      2023Tennessee Board of Medical Examiners
      2023Alabama Board of Medical Examiners
      2023Mississippi State Board of Medical Licensure
      2016American Board of Radiology
      2014DPS License
      2013DEA License
      2013Texas Medical License
      2009Basic Life Support

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Radiation Oncology, The University of Texas Medical Branch at Galveston, Galveston, Texas, 2021 - 2025

      Assistant Professor, Radiation Oncology, The University of Texas Medical Branch at Galveston, Galveston, Texas, 2017 - 2021

      Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021

      Administrative Appointments/Responsibilities

      Co-Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

      Liaison, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present

      Co-Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present

      Liaison, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present

      Liaison, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present

      Assistant Medial Director, The University of Texas MD Anderson Cancer Center, League City, TX, 2019 - Present

      Extramural Institutional Committee Activities

      Alternate member representing department of Genitourinary Radiation Oncology, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2026 - Present

      Committee Member, Breast Radiation Oncology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Benign Salivary Gland Tumor, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Benign Disease Working Group, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Prostate Center Champions Working Group, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Co-Chair, Technology Assessment Committee (TAC) within Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Prostate Cancer Demonstration Project, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Head and Neck Brocade Template Optimization Group, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Committee Member, Radiation Oncology Patient Experience Committee (ROPEC), The University of Texas MD Anderson Cancer Center, 2025 - Present

      Co-Chair, New Process Review Committee (NPR), The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Advanced Care Planning Radiation Oncology Working Group, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2022 - 2025

      Liaison, Radiation Oncology Cancer Network Program, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, CE&S Tube placement, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, One RO Patient Experience Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Committee Member, Radiation Oncology Tier 3.0, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Radiation Oncology COVID Recovery Workstream for Safety, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, MD Anderson Active Living After Cancer Program, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, League City HAL Engagement Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Member, Radiation Oncology Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Member, MD Anderson Cancer Center Radiation Oncology Burnout Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Panel Member, UT MD Anderson Focus on Junior faculty Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2017

      Chief Resident, UTMB Radiation Oncology Residency, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Member-At-Large Representative Elected by UTMB Chief Residents, UTMB Chief Resident/HOA Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Editorial Activities

      Reviewer, Advances in Cancer Education and Quality Improvement, 2025 - Present

      Honors & Awards

      2025 - PresentHAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2025 - 2026Top 10% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2024 - 2025HAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2023 - 2024Top 1% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2023 - 2024Mendy Jeter Excellence in Clinical Care Award, Division of Radiation Oncology
      2023HAL Research High Enroller with 5-10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2022 - 2024HAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2022 - 2023Top 1% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2021 - 2022HAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2020 - 2021HAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2020 - 2021Top 10% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2019 - 2020HAL Outstanding Research Enroller with >10% Yield of Consultations, The University of Texas MD Anderson Cancer Center
      2019 - 2020Top 1% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2018 - 2019Top 10% Performer CAHPS, The University of Texas MD Anderson Cancer Center Physician Referral Service
      2014 - 2015Top Doctor in Houston, TX 2014, Awarded by International Association of Radiologists. Published in The Leading Physicians of the World
      2014 - 2015Outstanding Overall Resident Award Nominee, University of Texas Medical Branch
      2014 - 2015American Brachytherapy Society Nucletron Scholarship, Willis Knighton Medical Center, Shreveport, LA
      2010 - 2011In-training Exam Award for Top Score, The Methodist Hospital
      2008 - 2009AOA Junior Medical student, Vice President of chapter, Alpha Omega Alpha, Texas Alpha Chapter

      Professional Memberships

      Society for Women in Radiation Oncology

      2022 - 2023

      American Board of Radiology

      2016 - Present

      Harris County Medical Society

      2014 - Present

      American Brachytherapy Society

      2014 - 2015

      American College of Radiation Oncology

      2013 - 2014

      American Society for Radiation Oncology

      2011 - Present

      Texas Radiologic Society

      2011 - 2014

      American College of Radiology

      2010 - 2014

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Head and Neck Contouring Pearls. Invited. NERO MDA Conference. Houston, Texas, US.
      2. 2024. DVH Constraints, Guidelines, Dose and Fractionation. Invited. NERO MDA Conference. Houston, Texas, US.

      Regional Presentations

      1. 2023. PSMA Positive Nodal Recurrence in Prostate Cancer. Christopher G Wood Advances in Urologic Oncology Symposium.

      National Presentations

      1. 2025. Oligometastatic HNSCC: Where are we now?. Invited. Ochsner 2025 Multidisciplinary Cancer Updates. New Orleans, LA, US.

      International Presentations

      1. 2019. Radiation Oncology updates in treatment of Prostate Cancer. Invited. World Cancer Congress September 24, 2019. Prague, CZ.
      2. 2019. Quantification and verification of skin dose for patients with head and neck cancer receiving intensity modulated proton therapy (IMPT). Conference. Particle Therapy Co-operative Group, June 10, 2019. Manchester, GB.
      3. 2009. Intracranial catheterization using a sacral hiatus access as an alternative for percutaneous intraspinal navigation: a study in cadavers. Invited. American Society of Neuroradiology Annual Meeting. Vancouver, CA.

      Formal Peers

      1. 2025. Head and Neck Contouring. Houston, Texas, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Zakaria El Kouzi MD, Ramez Kouzy MD, Asif Aziz MD, Michael K Rooney MD MS, Stephen R Lee MD, Stephen E McRae MD, Ketan Y Shah MD, Mohamed E Abdelsalam MD, Ethan Y Lin MD, Comron Hassanzadeh MD MPH, Seungtaek Choi MD, Quynh-Nhu Nguyen MD, Steven J Frank MD, Mohamed Shelan MD, Lauren L Mayo MD, Sean McGuire MD PhD, Steven Yevich MD MPH, Osama Mohamad MD PhD. Hyaluronic Acid Rectal Wall Infiltration and Reversal in Patients With Prostate Cancer Undergoing Radiation Therapy–A Case Series. Adv Radiat Oncol 11(11), 2026. e-Pub 2026.
      2. Mayo LL. Safety and Early Outcomes of External Beam Radiation Therapy with Low Dose Brachytherapy Boost in Patients with Prostate Cancer: A Single Institution Experience. Brachytherapy. e-Pub 2026.
      3. Mayo LL. Clinical Outcomes of Rectal Wall Infiltration Following Hydrogel Spacer Placement: A Single-Institution Retrospective Study. Adv Radiat Oncol. e-Pub 2026.
      4. Hong BH, Olabumuyi AA, Zhao S, Trivedi P, Putney R, Katende E, Serna A, Smith R, Dhillon J, Park J, Pessoa R, Poch M, Grass G, Pow-Sang J, Hakansson A, Liu Y, Davicioni E, Ren Y, Tang S, Croucher D, Huang H, Chang L, Feng M, Yamashita R, Ong E, Tay KJ, Tan K, L Tuan JK, C Wang ML, Khor LY, Jordan OG, Chang JH, Datnow-Martinez C, Shi X, Shetty A, Rana ZH, Molitoris J, Mishra MV, Kwok Y, Song Y, Ramotar M, Berlin A, Guler O, Onal C, Vaugier L, Blanc-Lapierre A, Supiot S, Mercier C, Dirix P, Ost P, Park R, Tang C, Rooney M, Shah S, Mayo L, Choi S, Frank S, Hassanzadeh C, Hoffman K, McGuire S, Mohamad O, Mok H, Nguyen Q, Patel K, DeWeese T, Kiess A, Song D, Delacroix S, Spratt D, Nguyen P, Deek M, Tran P, Sutera P, Chua M, Yamoah AK. Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer. Clinical Cancer Research. e-Pub 2026.
      5. Smith GL, Wu BC, Joyner BM, Schlembach P, Bloom ES, Reed CV, Graybill J, Anderson C, Dragun A, Ceilley GE, K Garg A, Freeman A, Diavolitsis V, Mayo LL, Bowers J, Neisler K, Reddy J, Ahlawat S, Khan M, Mitchell M, Arzu I, Y Tsuji S, DeHaan M, Jain S, Greenwalt J, Rehman S, Zaki M, Wei SJ, Chavez-MacGregor M, H Giordano S, Shen Y, Kaiser KW, Smith BD. Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial. Int J Radiat Oncol Biol Phys, 2026. e-Pub 2026.
      6. Sherry A, Haymaker C, Shuqi W, Suyu L, Tharakeswara B, Medina-Rosales M, Seo A, Hara K, Reddy J, Chun S, Mayo LL, Ghia A, Walker G, Pant S, Zhao D, Kovitz C, Ramirez D, Smith B, Gomez D, Cohen L, Reuben A, Tannir N, Corn P, Siddiqui B, Subudhi S, Msaouel P, Tang C. Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND Trial. Journal Clinical Oncology, 2026. e-Pub 2026. PMID: 42142259.
      7. Kouzi ZE, Chang E, Rooney MK, Rauch GM, Surabhi VR, Surabhi A, Mohamad O, Mayo L, Shah S, Tran P, Hassanzadeh C, Tang C, Mok H, Choi S, McGuire S, Hoffman K, Lee SR, Pera J, Balter P, Nguyen Q, Frank SJ. Clinical Outcomes of Rectal Wall Infiltration Following Hydrogel Spacer Placement: A Single-Institution Retrospective Study. Pract Radiat Oncol. e-Pub 2026.
      8. Mayo LL. Financial Toxicity Among Patients with Oropharyngeal Cancer Treated with IMPT and IMRT. Int J Radiat Oncol Biol Phys. e-Pub 2026.
      9. Yam C, Mayo LL, Korkut A. Multimodal Machine Learning Identifies a Molecular Signature of Treatment Response in Triple-Negative Breast Cancer: Insights from the ARTEMIS Trial. Cancer Cell. e-Pub 2026.
      10. Echere J, Onigbogi M, Hubbard Q, Tate M, Augustyn A, Arzu I, Mayo LL, Bloom E, Shah S, Chun S, Anakwenze C. Improving the Efficiency of Radiation Oncology Clinical Trial Enrollment in an Integrated Academic Satellite Network: Using a Plan-Do-Study-Act (PDSA) Methodology. JCO Oncology Practice. e-Pub 2026.
      11. Leone, A, Peterson, CB, Lee, A, Garden, AS, Gunn, GB, Mayo, LL, Moreno, AC, Frank, SJ, Fuller, C, Reddy, JP, Hoffman, K, Vazquez, I, Yang, M, Niedzielski, JS, Court, LE, Whitaker, TJ. Defining a Quantitative Threshold for Adaptive Re-planning using a Percentile-based Scoring System. International Journal of Particle Therapy 19, 2026. e-Pub 2026. PMID: 41737863.
      12. Hemmati M, Toumazis I, Lee J, Janbeh Sarayi SMM, Ning MS, Foote RL, Busse P, Rosenthal D, Garden AS, Patel SH, Snider JW, Gunn G, Molitaris J, Ma DJ, Parvathaneni U, Shah SJ, Lin A, Lee N, McDonald MW, Kalman NS, Katz SR, Bajaj GK, Hyde C, Henson CE, Dagan R, Nasiruddin M, Hernandez M, Swanson DS, Morrison WH, Fuller CD, Phan J, Moreno AC, Lee A, Spiotto MT, Mayo L, Liao JJ, Paly J, Chronowski GM, Reddy JP, Frank SJ. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: A cost-effectiveness analysis. Lancet Reg Health Am. e-Pub 2026.
      13. Patrick Carriere, Omar Alhalabi, Jianjun Gao, Amishi Shah, Sangeeta Goswami, Matthew Campbell, Ruitao Lin, Mayo LL, Osama Mohamad, Karen Hoffman, Henry Mok, Charmaigne Lozano, Ashish Kamat, Neema Navai, Kelly Bree, Byron Lee, Charles Guo, Michael Rooney, Chad Tang, Seungtaek Choi, Comron Hassanzadeh. Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract. Bladder Cancer 12(1), 2026. e-Pub 2026. PMID: 41550986.
      14. Frank SJ, Busse PM, Lee J, Rosenthal DI, Hernandez M, Swanson DM, Garden AS, Gunn G, Patel SH, Snider JW, Ma DJ, Molitoris JK, Lee NY, Parvathaneni U, McDonald MW, Kalman NS, Lin A, Mohammed N, Henson C, Hyde C, Bajaj GK, Katz SR, Dagan R, Morrison WH, Reddy JP, Fuller C, Shah SJ, Phan J, Chronowski GM, Mayo L, Sturgis EM, Ferrarotto R, Zhu XR, Zhang X, Wang L, Hutcheson KA, El-Naggar AK, Moreno AC, Lee A, Spiotto MT, Gross ND, Lai SY, Liao JJ, Paly J, Liao Z, Foote RL. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet 407(10524):174-184, 2025. e-Pub 2025. PMID: 41391462.
      15. Sherry AD, Siddiqui BA, Haymaker C, Fellman BM, Medina-Rosales MN, Bathala TK, Wang S, Liu S, Seo A, Hara K, Lu H, Troncoso P, Chun SG, Ha CS, Mayo LL, Mok H, Park RJ, Chapin BF, Phillips RM, Deek MP, Kovitz CA, Aparicio A, Zurita AJ, Pilie PG, Cohen L, Choi SL, Reuben A, Tran PT, Corn PG, Subudhi SK, Tang C. Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial. Eur Urol 88(5):496-509, 2025. e-Pub 2025. PMID: 40750497.
      16. Mohamad O, Kouzi ZE, Kouzy R, Choi S, Mok H, Hoffman K, Nguyen QN, Hassanzadeh CJ, Tang C, Park RJ, Shah SJ, McGuire SE, Mayo LL, Kim Y, Prajapati S, Vijayan S, Kudchadker RJ, Bruno TL, Frank SJ. Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer. Brachytherapy 24(2):301-309, 2025. e-Pub 2025. PMID: 40024668.
      17. Sherry A, A Siddiqui B, Haymaker C, M Fellman B, N Medina-Rosales M, Bathala T, liu S, Seo A, Hara K, Lu H, Troncoso P, G Chun S, Ha C, Mayo L, Mok H, Park R, Chapin BF, M Phillips R, Deek M, Kovitz C, Aparicio A, Zurita A, Pilie P, Cohen L, Choi S, Reuben A, Tran P, Corn P, Subudhi S, Tang C. Immune correlates of clinical benefit in patients with oligometastatic prostate cancer treated with metastasis-directed therapy. Nature Cancer. e-Pub 2025.
      18. Carriere, P, Alhalabi, O, Gao, J, Mohamad, O, Campbell, M, Shah, AY, Goswami, S, Bree, KK, Lee, B, Navai, N, Mok, H, Mayo, LL, Guo, CC, Nguyen, Q, McGuire, SE, Park, R, Shah, SJ, Hoffman, K, Frank, SJ, Tang, C, Choi, S, Kamat, A, Hassanzadeh, CJ. Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. Clinical and Translational Radiation Oncology 49, 2024. e-Pub 2024. PMID: 39403573.
      19. Chung CV, Khan MS, Olanrewaju A, Pham M, Nguyen QT, Patel T, Das P, O'Reilly MS, Reed VK, Jhingran A, Simonds H, Ludmir EB, Hoffman KE, Naidoo K, Parkes J, Aggarwal A, Mayo LL, Shah SJ, Tang C, Beadle BM, Wetter J, Walker G, Hughes S, Mullassery V, Skett S, Thomas C, Zhang L, Nguyen S, Mumme RP, Douglas RJ, Baroudi H, Court LE. Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites. Radiother Oncol 202:110609, 2024. e-Pub 2024. PMID: 39486482.
      20. Tino R, Roach MA, Fuentes GD, Agrawal A, Zaid M, Cooper DJ, Bajaj N, Lin R, Xiao L, Mayo LL, Wiederhold LR, Shah SJ, Tate MK, Chronowski GM, Reddy JP, Mezera M, Mann JM, Augspurger M, Otun AO, Chambers MS, Koay EJ. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncol 157:106944, 2024. e-Pub 2024. PMID: 39024700.
      21. Sosa AJ, Rooney MK, Thames HD, Sanders JW, Swanson DM, Choi SL, Nguyen QN, Mok H, Kuban DA, Ron Zhu X, Shah S, Mayo LL, Hoffman KE, Tang C, McGuire SE, Sahoo N, Zhang X, Lee AK, Pugh TJ, Mahmood U, Davis JW, Chapin BF, Corn P, Kudchadker R, Ausat N, Frank SJ. Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center. Clin Transl Radiat Oncol 48:100822, 2024. e-Pub 2024. PMID: 39188999.
      22. Williams TP, Cox MW, Jana B, Ross MI, Fisher SB, Walker JP, Hume CB, Mayo LL, Tyler DS. Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapy. J Surg Oncol 129(7):1209-1212, 2024. e-Pub 2024. PMID: 38534025.
      23. Leone AO, R Mohamed AS, Fuller CD, Peterson CB, Garden AS, Lee A, Mayo LL, Moreno AC, Reddy JP, Hoffman K, Niedzielski JS, Court LE, Whitaker TJ. A Visualization and Radiation Treatment Plan Quality Scoring Method for Triage in a Population-Based Context. Adv Radiat Oncol, 2024. e-Pub 2024. PMID: 38993196.
      24. Maroongroge, S, Mohamed, AS, Nguyen, C, Guma De la Vega, J, Frank, SJ, Garden, AS, Gunn, GB, Lee, A, Mayo, LL, Moreno, AC, Morrison, WH, Phan, J, Spiotto, MT, Court, LE, Fuller, C, Rosenthal, D, Netherton, T. Clinical acceptability of automatically generated lymph node levels and structures of deglutition and mastication for head and neck radiation therapy. Phys Imaging Radiat Oncol 29, 2024. e-Pub 2024. PMID: 38356692.
      25. Wang L, Sanders J, Ward JF, Lee SR, Poenisch F, Swanson DM, Sahoo N, Zhu XR, Ma J, Kudchadker RJ, Choi SL, Nguyen Q, Mayo LL, Shah SJ, Frank SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy. Cancers (Basel) 16(3):625, 2024. e-Pub 2024. PMID: 38339376.
      26. Sosa AJ, Thames HD, Sanders JW, Choi SL, Nguyen QN, Mok H, Ron Zhu X, Shah S, Mayo LL, Hoffman KE, Tang C, Lee AK, Pugh TJ, Kudchadker R, Frank SJ. Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center. Radiother Oncol 188:109854, 2023. e-Pub 2023. PMID: 37597805.
      27. Contrera KJ, Tam S, Pytynia K, Diaz Jr EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, T Pisters PW, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2331-2338, 2023. e-Pub 2023. PMID: 36581726.
      28. Reddy JP, Lei X, S Bloom YE, Reed VK, Schlembach PJ, Arzu I, Mayo L, Chun SG, Ahmad NR, Stauder MC, Gopal R, Kaiser K, Fang P, Smith BD, Trial Investigators YOBOTO. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase II Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 119(3):1034, 2023. e-Pub 2023. PMID: 36216274.
      29. McMillan H, A Barbon CE, Cardoso R, Sedory A, Buoy S, Porsche C, Savage K, Mayo LL, Hutcheson KA. Manual Therapy for Patients with Radiation-Associated Trismus After Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 148(5):418-425, 2022. e-Pub 2022. PMID: 35297966.
      30. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients with Breast Cancer Presenting with Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
      31. Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2021. e-Pub 2021. PMID: 35387420.
      32. Gunn GB, Garden AS, Ye R, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton Therapy for Head and Neck Cancer: A 12 Year Single-Institution Experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
      33. Smith GL, Fu S, Ning MS, Nguyen DK, Busse PM, Foote RL, Garden AS, Gunn GB, Fuller CD, Morrison WH, Chronowski GM, Shah SJ, Mayo LL, Phan J, Reddy JP, Snider JW, Patel SH, Katz SR, Lin A, Mohammed N, Dagan R, Lee NY, Rosenthal DI, Frank SJ. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer. Int J Part Ther 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
      34. Choi JS, Sansoni ER, Lovin BD, Lindquist NR, Phan J, Mayo LL, Ferrarotto R, Su SY. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review. Ann Otol Rhinol Laryngol 129(5):517-522, 2020. e-Pub 2020. PMID: 31875405.
      35. Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG. Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma with Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab. Front Oncol 9:223, 2019. e-Pub 2019. PMID: 31024834.
      36. Reed V, Kaw A, Patel H, Arzu I, Mayo L, Cohen L, Rosenthal D, Shah S. Employee Physical Activity in an Outpatient Oncology Clinic: A Baseline Pilot Study. Cureus 10(12):e3803, 2018. e-Pub 2018. PMID: 30868017.
      37. Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD. Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. Int J Comput Assist Radiol Surg 10(10):1667-73, 2015. e-Pub 2015. PMID: 25477277.

      Review Articles

      1. Mayo LL. Modern Trends in the Use of Postoperative Radiotherapy After Prostatectomy in Prostate Cancer. Prostate Cancer Prostatic Dis. e-Pub 2026.
      2. Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Spiotto MT, Chronowski G, Shah SJ, Mayo LL, Gross ND, Ferrarotto R, Zhu XR, Zhang X, Frank SJ. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: A De-Intensification Strategy. Curr Treat Options Oncol 22(6):54, 2021. e-Pub 2021. PMID: 34086150.
      3. Vicens RA, Rodriguez J, Sheplan L, Mayo C 3rd, Mayo L, Jensen C. Brachytherapy in pelvic malignancies: a review for radiologists. Abdom Imaging 40(7):2645-59, 2015. e-Pub 2015. PMID: 25820802.

      Editorials

      1. Mayo, L. Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy: Brown LC, Diehn FE, Boughey JC, et al (Mayo Clinic, Rochester, MN) Int J Radiat Oncol Biol Phys 92:642-649, 2015. Breast Diseases: A Yearbook Quarterly 26(4):339-341, 2015.

      Abstracts

      1. Lee A, Tino R, Roach M, Fuentes G, Agrawal A, Zaid M, Cooper D, Lin R, Xiao L, Mayo L, Wiederhold L, Shah S, Chronowski G, Reddy JP, Mezera M, Mann J, Augspurger M, Otun A, Chambers M, Koay E. A Randomized Study of Head and Neck Radiotherapy with or without Customized 3D Printed Oral Stents. Annual meeting of the American Society for Radiation Oncology [ASTRO]. e-Pub 2026.
      2. Kouzi ZE, Kouzy R, Aziz A, Rooney MK, Lee SR, McRae SE, Shah KY, Lin EY, Hassanzadeh C, Choi S, Nguyen Q, MDd MS, Mayo LL, Yevich S, Mohamad O. Hyaluronic Acid Rectal Wall Infiltration and Reversal in Patients with Prostate Cancer Undergoing Radiotherapy – A Case Series. Annual meeting of the American Society for Radiation Oncology [ASTRO]. e-Pub 2026.
      3. Sherry AD, Haymaker C, Fellman BM, Bathala TK, Medina-Rosales MN, Liu S, Chun SG, Mayo LL, Choi SL, Phillips RM, Deek MP, Aparicio A, Zurita AJ, Pilie PG, Siddiqui BA, Subudhi SK, Reuben A, Corn PG, Tran P, Tang C. Metastasis-Directed Therapy for Oligometastatic Prostate Cancer with Continuous or Intermittent Androgen Deprivation Therapy: Results of Two Phase II Randomized Trials from the EXTEND Study with Translational Correlatives. ASCO Genitourinary Cancers Symposium, 2025. e-Pub 2025.
      4. Mayo LL. Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer Following Transurethral Resection of Prostate or Laser Enucleation. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2025. e-Pub 2025.
      5. Mayo LL. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: Final Results of a Phase II Trial of Daily Partial Breast Irradiation. American Radium Society Annual Meeting, 2025. e-Pub 2025.
      6. Gupta H, Zakaria EK, Qureshi, Mustafa M, McGuire S, Shah S, Hoffman K, Tang C, Nguyen Quynh-Nhu MD, Mayo L, Mok H, Hassanzadeh C, Park R, Frank S, Choi S, Osama M. Changing Landscapes of Adjuvant Radiotherapy After Prostatectomy in Prostate Cancer. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2025. e-Pub 2025.
      7. Mayo LL. CONSOLIDATE: Concurrent Radiotherapy with Enfortumab vedotin (EV) for Locally Advanced Bladder Cancer. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2025. e-Pub 2025.
      8. Jacques Carriere PP, Alhalabi O, Gao J, Shah AY, Campbell MT, Mayo LL, Mohamad O, Hoffman KE, Mok H, Lozano C, Shah SJ, Park RJ, Mcguire SE, Kamat AM, Navai N, Bree K, Guo CC, Tang C, Choi S, Hassanzadeh C. Safety and Early Outcomes of External Beam Radiation Therapy with Brachytherapy Boost in Patients with Prostate Cancer: The MD Anderson Experience. ASCO Genitourinary Cancers Symposium, 2025. e-Pub 2025.
      9. Ansari M, Hoffman K, Mok H, Frank S, Nguyen Q, Tang C, McGuire S, Mayo L, Shah S, Prajapati S, Surasi D, Pilie P, Lozano C, Mohamad O, Choi S, Rooney M, Tran P, Hassanzadeh C. Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2025. e-Pub 2025.
      10. Mayo LL. A Double-Blinded Analysis of Anterior Oral Mucositis in Patients with Advanced Stage Oropharyngeal Cancer. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2025. e-Pub 2025.
      11. Mayo L. Phase III Randomized Trial IMPT vs IMRT OPC HNSCC. ASCO Annual Meeting, 2024. e-Pub 2024.
      12. Hooper J, Costello P, Phillips C, Mayo L. Treatment of breast lymphedema at a major cancer center. Oncology Rehabilitation in Practice, 2024. e-Pub 2025.
      13. Carriere PPJ, Alhalabi O, Gao J, Campbell M, Kamat A, Navai N, Lee B, Bree K, Tang C, Hoffman K, Choi S, Mohamad O, Mok H, Mayo LL, Hassanzadeh C. Evaluating the efficacy of radiation therapy in MTAP-deficient bladder cancer. American Radium Society Annual Meeting, 2024. e-Pub 2024.
      14. Carriere PPJ, Alhalabi O, Gao J, Campbell M, Kamat A, Navai N, Lee B, Bree K, Tang C, Hoffman K, Choi S, Mohamad O, Mok H, Mayo LL, Goswami S, Shah AY, Adibi M, McGuire SE, Hassanzadeh C. Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience. American Radium Society Annual Meeting, 2024. e-Pub 2024.
      15. Mayo LL. Proton Therapy with Brachytherapy Boost in Patients with Prostate Cancer: the MD Anderson Cancer Center Experience. American Brachytherapy Society Annual Meeting, 2024. e-Pub 2024.
      16. Surasi DS, Bathala T, Choi S, Shah S, Nguyen Q, Hoffman K, Mayo L, Mok H, Frank S, Fang A, Sheth R, Hwang K, Mawlawi O, Macapinlac H, Troncoso P, Zhang M, Pasyar S, Jr RB, Chapin B, Tang C. A Prospective Pilot Study Investigating 18F rhPSMA-7.3 PET/MRI to Detect Recurrent Disease and Guide Radiotherapy Planning in Patients with Biochemically Recurrent Prostate Cancer Post-Prostatectomy. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2024. e-Pub 2024.
      17. Mayo LL. Stereotactic Body Radiotherapy for Prostate Cancer with Magnetic Resonance Imaging or Computed Tomography Guidance. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2024. e-Pub 2024.
      18. Hoffman K, Shaitelman S, Qiao W, Zacharia R, Arzu I, Bloom E, Goodman C, Joyner M, Mayo LL, Mitchell M, Perkins G, Reddy J, Singh P, Stauder M, Strom E, Reed V, Schlembach P, Tereffe W, Woodward W, Smith B. Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated versus Conventionally Fractionated Regional Nodal Irradiation (RNI) for Invasive Breast Cancer. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2024. e-Pub 2024.
      19. Patrick Pierre-Jacques Carriere, Kuban D, Tang C, Mok H, Mayo LL, Choi S, Park RJ, Frank SJ, Nguyen QN, Hoffman K, Hassanzadeh C. Real-World Outcomes of Bladder-Preserving Radiation Therapy for Patients with Locally Advanced and Node-Positive, Non-Metastatic Bladder Cancer. ESTRO Annual Meeting, 2024. e-Pub 2024.
      20. Goodman C, Mitchell M, Ramezani S, Shaitelman S, Fnu R, Arzu I, Bloom E, Fuller CD, Joyner M, Mayo L, Nead K, Perkins G, Reddy J, Singh P, Stauder M, Strom E, Reed V, Schlembach P, Woodward W, Smith BD, Hoffman KE. Association of VMAT vs 3D-CRT Radiotherapy Treatment Technique with Acute Toxicity of Regional Nodal Irradiation: A Secondary Analysis of the SAPHIRe Phase III Randomized Clinical Trial. San Antonio Breast Cancer Symposium, 2024. e-Pub 2024.
      21. Hoffman K, Shaitelman S, Qiao W, Fnu R, Arzu I, Bloom E, Goodman C, Joyner M, Mayo L, Mitchell M, Perkins GH, Reddy J, Singh P, Stauder M, Strom E, Reed V, Schlembach P, Tereffe W, Woodward W, Smith B. Primary Outcome Analysis for Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized, Phase III Trial of Hypo- vs. Conventionally Fractionated Regional Nodal Irradiation (RNI). Annual meeting of the American Society for Radiation Oncology [ASTRO], 2024. e-Pub 2024.
      22. Tino R, Roach M, Fuentes GD, Agrawal A, Zaid M, Mann JM, Mezera M, Chronowski GM, Reddy JP, Mayo LL, Wiederhold LR, Shah SJ, Augspurger M, Chambers MS, Koay EJ. Initial clinical implementation of a Fully Customized Oral Stent Fabricated Using Intraoral Scanning (IOS) and Stereolithography (SLA) 3D printing for patients with oropharyngeal cancer receiving Radiotherapy (RT). CPRIT Innovations in Cancer Prevention and Research Conference, 2023. e-Pub 2023.
      23. Leone AO, R Mohamed AS, Fuller CD, Peterson CB, Garden AS, Lee A, Mayo LL, Reddy JP, Hoffman K, Moreno AC, Niedzielski JS, Court LE, Whitaker TJ. A plan scoring methodology with a visual tool for triage of plan quality in a population-based context. AAPM Annual Meeting, 2023. e-Pub 2023.
      24. Maroongroge S, Nguyen C, Moreno AC, Rosenthal DI, Mayo LL, Garden AS, Gunn G, Phan J, Lee A, Fuller CD, Morrison WH, Spiotto MT, Court LE, Netherton TJ. Clinical acceptability of Automatically Generated Lymph Nodes for Head and Neck Cancer Patients. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2023. e-Pub 2023.
      25. McMillian H, Cardoso R, Mayo LL, Sedory A, Porsche C, Savage K, Barbon C, Buoy S, Hutcheson K. Manual Therapy for Radiation-Associated Trismus: A Case Series. American Head & Neck Society Annual Meeting, 2021. e-Pub 2021.
      26. Philip N, Ye R, Hwang H, Wang X, Anscher MS, Chung SG, Choi S, Hoffman KE, Mayo LL, Nguyen QN, Shah SJ, Tang C, Davis J, Corn P, Troncoso P, Choi H, Kuban DA, Pugh TJ, Mahmood U, Lee AK Frank SJ. A phase II trial of hypofractionated proton therapy in prostate cancer: 3-year patient and physician reported outcomes. Annual Meeting of the American Society for Radiation Oncology [ASTRO], 2019. e-Pub 2019.
      27. Gunn GB, Garden AS, Ye R, Ausat N, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Rosenthal DI, Frank SJ. Clinical outcomes after proton therapy for head and neck cancer: a 12-year single-institution experience. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2019. e-Pub 2019.
      28. Reddy JP, Lindsay WD, Berlind CG, Ahern CA, Holmes A, Smith BD, Phan J, Frank SJ, Gunn GB, Rosenthal DI, Morrison WH, Garden AS, Chronowski G, Shah SJ, Mayo LL, Fuller CD. Applying a machine learning approach to predict acute radiation toxicities for head and neck cancer patients. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2019. e-Pub 2019.
      29. Fang P, Bloom E, Woodward WA, Stauder MC, Tereffe W, Chun SG, Schlembach PJ, Mayo LL, Ahmad N, Arzu IY, Reed VK, Chronowski GM, Delclos ME, Smith BD. A phase 2 study of hypofractionated partial breast irradiation (HF-PBI) in women with early-stage breast cancer. Annual meeting of the American Society for Radiation Oncology [ASTRO], 2018. e-Pub 2018.
      30. Mayo LL. Head-to-Head Comparison of Artificial Intelligence and Conventional Computer Aided Detection for Evaluation of Screening Mammograms. 119th Annual Meeting of the American Roentgen Ray Society [ARRS], 2018. e-Pub 2018.
      31. Mayo LL. Brachytherapy gadgets (instruments, applicators, and seeds): A review for Radiologist. American Roentgen Ray Society annual meeting, 2014. e-Pub 2014.
      32. Mayo LL. Cadaveric study of percutaneous cervical epidural catheterization through the sacral hiatus. American Society of Spinal Radiology Annual Meeting, 2014. e-Pub 2014.
      33. Mayo LL. Management of synchronous primary rectal and prostate cancers: A case report and dosimetric comparison. American College of Radiation Oncology annual meeting, 2014. e-Pub 2014.
      34. Mayo LL. Scalp sparing whole brain radiation therapy: Is IMRT and IGRT required. American Radium Society Annual Meeting, 2012. e-Pub 2012.
      35. Mayo LL. Intracranial catheterization using a sacral hiatus access as an alternative for percutaneous intraspinal navigation: a study in cadavers. National Student Research Forum, 2009. e-Pub 2009.
      36. Mayo LL. A novel approach to percutaneous intraspinal navigation through the sacral hiatus: CT evaluation of caudal vs. lumbar access. American Society of Neuroradiology Annual Meeting, 2008. e-Pub 2008.
      37. Mayo LL. Percutaneous epidural navigation guided with fluoroscopy: a cadaveric study. National Student Research Forum, 2008. e-Pub 2008.

      Letters to the Editor

      1. Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Lee, A, Koay, EJ. Response to recent comments on “Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy”. Oral Oncology 162, 2025.
      2. Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol 58: 1135-1137, 2019.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 09, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Radiation Therapy Treatment

      • Radiation Treatment Center

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top